Page 11 of 32

PA24.{2,4} | Alcoholic Liver Disease, Cirrhosis & Hepatic Failure — SDL Guide (Part 2)

Stage 3: Alcoholic Cirrhosis

Four-panel medical diagram explaining alcoholic cirrhosis pathogenesis, gross liver morphology, nodular patterns, and microscopic bridging fibrosis with regenerative nodules.

Alcoholic Cirrhosis: Fibrosis, Nodules, and Histology

Panel A: Repeated hepatocyte injury and death; Kupffer cell; damaged hepatocyte; TGF-beta; hepatic stellate cell / Ito cell; vitamin-A-storing lipocyte; myofibroblast; type I and III collagen; progressive fibrosis; bridging fibrosis; regenerative nodules.. Panel B: Firm nodular liver surface; enlarged to atrophic liver; tan-yellow regenerative nodules; grey-white fibrous bands; cut surface of cirrhotic liver.. Panel C: Micronodular cirrhosis / Laennec cirrhosis; uniform nodules under 3 mm; evenly distributed fibrosis; mixed or macronodular cirrhosis; irregular nodules over 3 mm; time or abstinence transition.. Panel D: Portal tract; central vein; bridging fibrosis from portal tract to portal tract; bridging fibrosis from portal tract to central vein; regenerative nodule lacking portal tracts and central veins; bile ductular proliferation; destroyed lobular architecture..

Alcoholic cirrhosis is the irreversible end-stage of alcoholic liver disease, developing in approximately 10–20% of chronic heavy drinkers after 10–20 years.

Pathogenesis of fibrosis: Repeated hepatocyte injury and death → activation of hepatic stellate cells (Ito cells) by TGF-β (released from Kupffer cells and damaged hepatocytes) → stellate cells transform from vitamin-A-storing lipocytes into myofibroblasts → synthesise type I and III collagen → progressive fibrosis.

Pattern: Alcoholic cirrhosis initially produces micronodular cirrhosis (Laennec's cirrhosis):
• Regenerative nodules are small, uniform, <3 mm
• Fibrosis is evenly distributed throughout the parenchyma
• Reflects uniform zonal injury from alcohol

With time or after abstinence, micronodular cirrhosis may convert to a mixed or macronodular pattern (nodules >3 mm, irregular sizes).

Gross morphology: Liver is initially enlarged, then atrophic; firm, nodular surface; cut section shows tan-yellow nodules separated by grey-white fibrous bands.

Microscopy:
• Bands of fibrous tissue (bridging fibrosis) linking portal tracts to central veins and portal tract to portal tract
• Regenerative nodules (parenchyma without portal tracts or central veins)
• Destruction of normal lobular architecture — this is the defining histological criterion of cirrhosis
• Bile ductular proliferation at fibrous septa

Irreversibility: Once bridging fibrosis with regenerative nodules is established, normal architecture cannot be restored. This is in contrast to steatosis and alcoholic hepatitis, which can regress with abstinence.

Side-by-side medical illustration of alcoholic cirrhosis showing a small nodular liver surface grossly and H&E histology with regenerative nodules separated by fibrous septa.

Alcoholic Cirrhosis: Gross and H&E Features

Panel A: Gross cirrhotic liver showing small nodular liver surface, fibrous bands, and regenerative nodules.. Panel B: H&E histology showing micronodular regenerative nodules, fibrous septa, absence of portal tract within a nodule, and loss of normal lobular architecture..

Cirrhosis: General Definition, Aetiology & Classification

Diagram showing alcoholic cirrhosis as a micronodular, fibrotic end-stage liver disease caused by alcohol-induced hepatocyte injury, stellate cell activation, and collagen deposition.

Alcoholic Cirrhosis: Pathogenesis and Micronodular Pattern

Panel A: Normal smooth liver, alcoholic cirrhosis, shrunken yellow-brown liver, micronodules <3 mm, evenly distributed fibrosis, regenerative nodules. Panel B: Chronic alcohol injury, hepatocyte injury and death, Kupffer cells, damaged hepatocytes, TGF-beta, hepatic stellate cells, myofibroblasts, type I and III collagen. Panel C: Regenerative nodules, fibrous septa, activated stellate cells, space of Disse, collagen fibers, distorted hepatic plates, vitamin-A-storing lipocyte, collagen-producing myofibroblast.

Cirrhosis is defined as diffuse hepatic fibrosis with regenerative nodule formation, resulting in complete distortion of the normal lobular and vascular architecture. It is the final common pathway of many forms of chronic liver disease.

Causes — in approximate frequency in India:

AetiologyNotes
Alcohol (most common in urban centres)Micronodular early
Chronic hepatitis B/CMacronodular; B is dominant in India
Non-alcoholic steatohepatitis (NASH)Metabolic syndrome; rising rapidly
Biliary cirrhosisPrimary (PBC, PSC) or secondary (biliary obstruction)
HaemochromatosisHereditary iron overload; brownish liver
Wilson diseaseCopper accumulation; younger patients
Autoimmune hepatitisYoung women; ANA/SMA positive
Cryptogenic~10%; possibly NASH

Micronodular vs Macronodular:
Micronodular (<3 mm, uniform): alcohol, haemochromatosis, primary biliary cirrhosis, cardiac cirrhosis
Macronodular (>3 mm, irregular): chronic viral hepatitis, Wilson disease, alpha-1-antitrypsin deficiency; higher risk of hepatocellular carcinoma
• Mixed pattern: seen in advanced or treated disease

Regardless of aetiology, once established, cirrhosis leads to the same downstream consequences: portal hypertension, hepatocellular failure, and increased risk of hepatocellular carcinoma.

CLINICAL PEARL

AST:ALT > 2:1 in alcoholic liver disease — a teachable ratio: Alcohol suppresses hepatic pyridoxal phosphate (vitamin B6), which is a cofactor required by ALT (but not AST) for synthesis. The result is disproportionately low ALT relative to AST. A ratio >2 strongly suggests alcoholic aetiology; a ratio >3 is almost diagnostic. In viral hepatitis, both enzymes rise proportionately (ratio <1). In NASH, the ratio is usually <1. This single ratio helps differentiate three of the most common causes of elevated transaminases at the bedside.

Hepatic Failure: Acute vs Chronic

A four-panel medical education diagram compares acute fulminant hepatic failure with chronic cirrhotic failure, showing timelines, causes, lobular necrosis, histology, ACLF triggers, and functional complications.

Hepatic Failure: Acute vs Chronic

Panel A: Acute/Fulminant Hepatic Failure; Chronic/Cirrhotic Failure; days-weeks; years; previously healthy liver; cirrhosis; massive hepatocyte necrosis; progressive loss of functional hepatocyte mass; synthetic function; detoxifying function; metabolic function; 50-90% mortality without transplantation. Panel B: Hepatic lobule; central vein; portal triads; Zone 3 necrosis; most oxygen-poor zone; paracetamol toxicity; ischaemic hepatitis; HAV; HBV; HEV in pregnancy; Amanita phalloides; acute fatty liver of pregnancy. Panel C: Massive necrosis; submassive necrosis; confluent hepatocyte dropout; collapsed reticulin framework; bridging necrosis; preserved portal tracts; ghost lobules. Panel D: Cirrhotic liver; acute-on-chronic hepatic failure; infection; variceal bleeding; drugs; alcohol binge; protein synthesis failure; albumin; clotting factors; detoxification failure; ammonia; bilirubin conjugation; metabolic failure; glucose; lipids; hormones.

Hepatic failure is defined as loss of sufficient hepatic function — synthetic, detoxifying, metabolic — to sustain life. It presents in two distinct clinical patterns.

Acute (Fulminant) Hepatic Failure:
• Massive hepatocyte necrosis over days–weeks in a previously healthy liver
• Causes: acute viral hepatitis (HAV, HBV, HEV in pregnancy), paracetamol overdose, Amanita phalloides mushroom poisoning, acute fatty liver of pregnancy, ischaemic hepatitis
Zone 3 necrosis (centrilobular): seen in paracetamol toxicity and ischaemia (most oxygen-poor zone)
Massive/submassive necrosis: entire lobule or bridging necrosis across multiple lobules
• Histology: confluent hepatocyte dropout with collapsed reticulin framework, preserved portal tracts ("ghost" lobules)
• Prognosis: 50–90% mortality without liver transplantation

Chronic Hepatic Failure (Cirrhotic Failure):
• Insidious loss of function over years as functional hepatocyte mass decreases
• End-stage complication of cirrhosis from any cause
Acute-on-chronic hepatic failure (ACLF): acute deterioration of stable cirrhosis, triggered by infection, variceal bleeding, drugs, or alcohol binge; high short-term mortality

Why so many complications? The liver performs >500 distinct functions. Its failure simultaneously disrupts:
• Protein synthesis (albumin, clotting factors)
• Detoxification (ammonia, drugs, bilirubin conjugation)
• Metabolism (glucose homeostasis, lipid metabolism, hormone inactivation)
• Haemodynamics (altered sinusoidal and splanchnic pressures)